AltStreet
EDGAR Verified
Primary Source · SEC.gov

Echo Life Sciences Fund, LP

CIK 0001860720Fund Vehicle2023 vintage506(b), 3(c)(1)

Raised

$12M

Investors

9

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Echo Life Sciences Fund, LP is a Delaware limited partnership that has raised $12.3M from 9 investors under Rule 506(b) and Section 3(c)(1). The fund, managed by Echo Investment Capital, LLC with executive officer Michael Kanady, focuses on longevity biotech investments. This is an amended filing with no minimum investment disclosed.

This longevity biotech fund follows a typical private placement structure using 506(b) exemption, indicating pre-existing relationships with accredited investors. With an average check size of approximately $1.4M across 9 investors, the fund sits in the emerging manager tier for specialized life sciences strategies focused on aging and longevity research.

Data Flags

generalAmendment filing with relatively modest raise ($12.3M) and small investor base (9) suggests early-stage close or targeted first institutional tranche
related_personsEntity name prefix 'n/a' appears in related persons roster for Echo O-Bio Fund I GP, LLC and Echo Investment Capital, LLC, indicating possible data quality issue in original filing

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001860720
Entity NameEcho Life Sciences Fund, LP
Exemption506(b), 3(c)(1)
First Sale Date—
Filing DateJuly 7, 2023
Accession Number0001860720-23-000001
Total Amount Sold$12M
Total Investors9
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

n/a Echo O-Bio Fund I GP, LLC

Promoter · Oklahoma City, OK

n/a Echo Investment Capital, LLC

Executive Officer · Oklahoma City, OK

Michael Kanady

Executive Officer · Oklahoma City, OK

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.